НЕЙРОПСИХИАТРИЧЕСКИЕ ПОСЛЕДСТВИЯ COVID-19

Петрова Н.Н.

DOI: 10.32415/jscientia_2022_8_4_5�14

��

EDN: BUEPRW

�� COVID-19

�. �. ��

��-�� , ��-��, ��

. �� petrova_nn@mail.ru

�� . � �� , �� NICE � ��, �� . �� , �� , ��, �� , ��. � �� , � �� -�� . �� , �� , �� . ��, �� . �� COVID-19, �� , �� .

�� : COVID-19, �� , �� , ��, ��, ��, �� , �� .

�� : �� .�. �� COVID-19 // Juvenis scientia. 2022. �� 8. � 4. �. 5�14. DOI: 10.32415/jscientia_2022_8_4_5-14. EDN: BUEPRW.

�� Creative Commons �Attribution� (��) 4.0 ��.

DOI: 10.32415/jscientia_2022_8_4_5�14

Review article

EDN: BUEPRW

NEUROPSYCHIATRIC CONSEQUENCES OF COVID-19

N. N. Petrova

Saint Petersburg State University, Saint Petersburg, Russia

. Petrova Nataliia � petrova_nn@mail.ru

A review of the literature is devoted to post-COVID neuropsychiatric disorders. The article reveals the concept of post-COVID syndrome, provides the definitions of NICE and WHO, describes the clinical pic�ture of post-COVID as a systemic disease. Data are provided on the increase in psychiatric morbidity at various times after the coronavirus infection, including depression, anxiety, cognitive impairment, and asthenia. An asthenoneurotic symptom complex with severe asthenia and cognitive dysfunction, which is often accompanied by prolonged anxiety-depressive symptoms, is described as the main char�acteristic of the post-COVID syndrome. Cognitive impairments within the framework of the post-COVID syndrome are mainly represented by memory impairments, a decrease in the ability to concentrate, deterioration in executive functions, regardless of age and previous cognitive deficit. It was noted that delirium in the acute period of coronavirus infection is a significant risk factor for the development of cognitive impairment in the post-COVID period. The proposed mechanisms and risk factors for the neuropsychiatric consequences of COVID-19 are described, while the importance of systemic inflamma�tion as the leading pathogenetic mechanism of post-COVID mental disorders is emphasized.

KEYWORDS: COVID-19, post-COVID syndrome, neuropsychiatric disorders, asthenia, depression, anxi�ety, cognitive impairment, development mechanisms.

FOR CITATION: Petrova NN. Neuropsychiatric consequences of COVID-19. Juvenis scientia. 2022;8(4):5� 14. DOI: 10.32415/jscientia_2022_8_4_5-14.

This article is licensed under a Creative Commons Attribution 4.0 International License.

��

�� (10-30 % �� ), �� , �� SARS-CoV-2, �� , �� COVID-19, �� [1].

�� long-COVID� � �� . �� , �� post-acute COVID-19 syndrome, �. �. �� COVID-19� �� [2]. �� NICE (National Institute for Health and Care Excellence), �� -COVID-19-�� , �� COVID-19, �� 12 �� . �� COVID� �� COVID� �� , �� COVID-19. �� COVID-19 (�� 4 �� 12 ��), �� -COVID-19-�� (12 �� ) [3]. � �� 2021 �� : �� SARS-CoV-2, �� , �� 3 �� COVID-19, � ��, �� 2 �� [4].

�� : �� ӭ��

�� , ��-��, �� . �� 15 �� , �� 440 800 �� 17 �� 87 �� , �� 80% �� , � � �� , �� COVID-19. �� 55 ��, � �� , �� : �� (58 %), �� (44 %), �� (25%), ��, ��, �� [5]. �� , ��, �� -�� , �� , �� (��), �� , �� , �� . �� , �� , �� , �� [6, 7].

�� , �� , �� , �� , �� 60 � 90 �� COVID-19: 56% � 35% �� : 27% � 26% �� , ��. �� , �� , ��, ��, �� [8].

�� 2 �� , �� 6 �� COVID-19, �� [9]. �� SARS-CoV-2 �� , � �� /�� [10]. �� , � �� , �� COVID-19 [11]. �� 6 �� COVID-19 13% �� 236 �� [12]. �� 30 � �� SARS-CoV-2, �� , �� , �� , �� [13]. �� (��, ��, �� ) �� 6 �� [14].

�� , �� COVID-19 �� 47%, 45% �34%, �� [8]. �� 12 �� 11-28%, � �� 3-12 % [15]. �� 6 �� COVID-19 �� , �� [16].

�� , �� 2 �� 10 ��, �. �. � �� -10 � NICE � �� (�� 4 �� ), �� (�� , ��, �� ), � �� -�� . �� [17].

�� [18]. 18% ��, �� COVID-19, �� 16 % � � �� [7]. ��-�� 50 % �� COVID-19, �� [19]. 28-56% �� COVID-19 �� , �� (��, ��, �� ) [20]. �� , �� , �� (�� ). �� (��. 1). �� , �� COVID-19 �� (��) [21]. �� [22].

��

�� COVID-19, �� (�� , ��-�� ), � �� [23, 24]. ��, �� SARS-CoV-2, �� , �� , ��-��, ��

��

�� , �� , �� , �� , ��

��

�� , ��

��

�� 1. �� , �� COVID-19 (�� ) [21]

��. �� , �� [25]. ��, ��, ��, in vitro, ��, � �� , �� [26]. �� [27-30]. �� . �� -��, ��-6, ��-1 ��, ��-��, �� . �� , �� [31]. �� . �� -1 ��, �� [32]. �� , �� , �� .

�� , �� , �� , �� , �� [33, 34]. �� , �� , �� [35]. �� COVID-19 �� [36]. �� COVID-19, �� , �� [37]. �� , �� , �� , �� . �� [38]. �� [39]. �� (��, ��, ��) �� [40].

�� [41]. �� [42]. �� , �� , �� [22].

�� COVID-19 �� . ��, �� SARS-CoV-2 �� , �� , �� . � �� COVID-19 �� , �� , �� , �� , �� , ��, �� [43, 44]. �� (�� ) �� , �� [45]. COVID-19 �� [46, 47]. �� , �� [48]. � �� , �� [21].

��

�� COVID-19 �� . � �� , ��, �� COVID-19 [49]. �� , �� , ��, � �� , � �� , �� [50].

�� , �� . �� , �� SARS-CoV-2, �� , �� COVID-19. �� [51].

�� , �� . ��

�� [REFERENCES]

�� -�� , �� , �� , �� [52, 53]. �� , �� [54-56].

��: �� .

�� : �� .

1. Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective poten�tial therapies. Rev Med Virol. 2022;32(4):e2315. DOI: 10.1002/rmv.2315

2.

Montani D, Savale L, Beurnier A, et al. Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls. Eur Respir J. 2021;58(1):2101090. DOI: 10.1183/13993003.01090-2021

3.

COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); December 18, 2020.

4.

World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. URL: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condi�tion-Clinical_case_definition-2021.1

5.

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a sys�tematic review and meta-analysis. Sci Rep. 2021;11(1):16144. DOI: 10.1038/s41598-021-95565-8

6.

Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. DOI: 10.1136/bmj.n1648

7.

Wu L, Wu Y, Xiong H, et al. Persistence of Symptoms After Discharge of Patients Hospitalized Due to COVID-19. Front Med (Lausanne). 2021;8:761314. DOI: 10.3389/fmed.2021.761314

8.

Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90-111. DOI: 10.1111/nyas.14506

9.

Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995-998. DOI: 10.1021/acschemneuro.0c00122

10.

Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2022;13(1):17-23. DOI: 10.1111/cen3.12676

11.

Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627. DOI: 10.1016/S2215-0366(20)30203-0

12.

Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416�427. DOI: 10.1016/S2215-0366(21)00084-5

13.

Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993. DOI: 10.1136/bmj-2021-068993

14.

Shanbehzadeh S, Tavahomi M, Zanjari N, et al. Physical and mental health complications post-COVID-19: Scoping review. J Psychosom Res. 2021;147:110525. DOI: 10.1016/j.jpsychores.2021.110525

15.

Daher A, Cornelissen C, Hartmann NU, et al. Six Months Follow-Up of Patients with Invasive Mechanical Ventilation due to COVID-19 Related ARDS. Int J Environ Res Public Health. 2021;18(11):5861. DOI: 10.3390/ ijerph18115861

16.

Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416�427. DOI: 10.1016/S2215-0366(21)00084-5

17.

Beaud V, Crottaz-Herbette S, Dunet V, et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry. 2021;92(5):567-568. DOI: 10.1136/jnnp-2020-325173

18.

Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258-263. DOI: 10.1016/j.cmi.2020.09.052

19.

Lambert NJ, Survivor Corps. COVID-19 �Long Hauler� Symptoms Survey Report. Indiana University School of Medicine; 2020. URL: https://dig.abclocal.go.com/wls/documents/2020/072720-wls-covid-symptom�study-doc.pdf.

20.

Damiano RF, Guedes BF, de Rocca CC, et al. Cognitive decline following acute viral infections: litera�ture review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci. 2022;272(1):139-154. DOI: 10.1007/s00406-021-01286-4

21.

Hampshire A, Trender W, Chamberlain SR, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. DOI: 10.1016/j.eclinm.2021.101044

22.

�� .�. �� SARS-CoV-2 // �� . 2021. � 3. �. 2-23. [Mosolov SN. Long-term psychiatric sequelae of SARS-CoV-2 infection. Current Therapy of Mental Disorders. 2021;(3):2-23. (in Russ)]. DOI: 10.21265/PSYPH.2021.31.25.001. EDN: YLXJWB.

23.

Sher L. Are COVID-19 survivors at increased risk for suicide? Acta Neuropsychiatr. 2020;32(5):270. DOI: 10.1017/neu.2020.21

24.

Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry. 2020;10(1):261. DOI: 10.1038/s41398-020-00949-5

25.

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronavi�ruses. Brain Behav Immun. 2020;87:18-22. DOI: 10.1016/j.bbi.2020.03.031

26.

Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12(1):14. DOI: 10.3390/v12010014

27.

Dantzer R. Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. Physiol Rev. 2018;98(1):477-504. DOI: 10.1152/physrev.00039.2016

28.

Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264�7275. DOI: 10.1128/JVI.00737-08

29.

Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22-34. DOI: 10.1038/nri.2015.5

30.

Najjar S, Pearlman DM, Alper K, et al. Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013;10:43. DOI: 10.1186/1742-2094-10-43

31.

Mingoti MED, Bertollo AG, Simoes JLB, et al. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci. 2022;72(6):1166-1181. DOI: 10.1007/s12031-022-02004-y

32.

Montani D, Savale L, Noel N, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31(163):210185. DOI: 10.1183/16000617.0185-2021

33.

Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912-920. DOI: 10.1016/S0140-6736(20)30460-8

34.

Carvalho PMM, Moreira MM, de Oliveira MNA, et al. The psychiatric impact of the novel coronavirus out�break. Psychiatry Res. 2020;286:112902. DOI: 10.1016/j.psychres.2020.112902

35.

Ismael F, Bizario JCS, Battagin T, et al. Post-infection depressive, anxiety and post-traumatic stress symp�toms: A prospective cohort study in patients with mild COVID-19. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110341. DOI: 10.1016/j.pnpbp.2021.110341

36.

Javelot H, Weiner L, Hingray C, et al. COVID-19 and its psychological consequences: Beware of the respirato�ry subtype of panic disorder. Respir Physiol Neurobiol. 2020;282:103530. DOI: 10.1016/j.resp.2020.103530

37.

Lee CH, Giuliani F. The Role of Inflammation in Depression and Fatigue. Front Immunol. 2019;10:1696. DOI: 10.3389/fimmu.2019.01696

38.

Mazza MG, Palladini M, De Lorenzo R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138-147. DOI: 10.1016/j.bbi.2021.02.021

39.

Okusaga O, Yolken RH, Langenberg P, et al. Association of seropositivity for influenza and coronavi�ruses with history of mood disorders and suicide attempts. J Affect Disord. 2011;130(1-2):220-225. DOI: 10.1016/j.jad.2010.09.029

40.

Robinson-Agramonte MA, Goncalves CA, Noris-Garcia E, et al. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatry. 2021;11(7):347-354. DOI: 10.5498/wjp.v11.i7.347

41.

Seang S, Itani O, Monsel G, et al. Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up. Infect Dis Now. 2022;52(3):165-169. DOI: 10.1016/j. idnow.2022.02.005

42.

Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. DOI: 10.1016/j. lanepe.2021.100122

43.

Lasso G, Honig B, Shapira SD. A Sweep of Earth�s Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease. Cell Syst. 2021;12(1):82-91.e3. DOI: 10.1016/j. cels.2020.09.006

44.

Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, et al. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins� Mimicry of Human Protein Interactions. Front Hum Neurosci. 2021;15:656313. DOI: 10.3389/fnhum.2021.656313

45.

Kas A, Soret M, Pyatigoskaya N, et al. The cerebral network of COVID-19-related encephalopathy: a longitu�dinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 2021;48(8):2543-2557. DOI: 10.1007/ s00259-020-05178-y

46.

Beaud V, Crottaz-Herbette S, Dunet V, et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry. 2021;92(5):567-568. DOI: 10.1136/jnnp-2020-325173

47.

Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. DOI: 10.1002/ jmv.26368

48.

Robinson-Agramonte MA, Goncalves CA, Noris-Garcia E, et al. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatry. 2021;11(7):347-354. DOI: 10.5498/wjp.v11.i7.347

49.

Shi J, Gao Y, Zhao L, et al. Prevalence of delirium, depression, anxiety, and post-traumatic stress disorder among COVID-19 patients: protocol for a living systematic review. Syst Rev. 2020;9(1):258. DOI: 10.1186/ s13643-020-01507-2

50.

�� .�., �� .�., �� .�. �� : �� , �� // ��, ��,

��. 2021. �. 13. � 3. �. 93-98. [Khasanova DR, Zhitkova YV, Vaskaeva GR. Post-COVID

syndrome: a review of pathophysiology, neuropsychiatrie manifestations and treatment perspectives.

Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):93-98. (in Russ)]. DOI: 10.14412/2074-2711�

2021-3-93-98. EDN: YJESZP.

51.

Deer RR, Rock MA, Vasilevsky N, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722. DOI: 10.1016/j.ebiom.2021.103722

52.

Roth A, Chan PS, Jonas W. Addressing the Long COVID Crisis: Integrative Health and Long COVID. Glob Adv Health Med. 2021;10:21649561211056597. DOI: 10.1177/21649561211056597

53.

Verduzco-Gutierrez M, Estores IM, Graf MJP, et al. Models of Care for Postacute COVID-19 Clinics: Experiences and a Practical Framework for Outpatient Physiatry Settings. Am J Phys Med Rehabil. 2021;100(12):1133-1139. DOI: 10.1097/PHM.0000000000001892

54.

Ritchie K, Chan D. The emergence of cognitive COVID. World Psychiatry. 2021;20(1):52-53. DOI: 10.1002/ wps.20837

55.

Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 -A systematic review. Brain Behav Immun. 2021;97:328-348. DOI: 10.1016/j.bbi.2021.07.018

56.

�� .�., �� .�., �� .�., �� .�. �� , �� COVID-19 // ��.��. 2021. �. 20. � 5. �. 6-12. [Kostenko EV, Eneeva MA, Petrova LV, Pogonchenkova IV. Cognitive disorders and neuropsychiatric sequellae associated with COVID-19. Doctor.Ru. 2021;20(5):6-12. (in Russ)]. DOI: 10.31550/1727-2378-2021-20-5-6-12. EDN: NRPBOE.

�� [AUTHOR]

. �� , �� , ��, �� -�� ; ORCID: 0000�0003-4096-6208; e-mail: petrova_nn@mail.ru.

. Petrova Nataliia Nikolaevna, Doctor of Medical Sciences, professor, Head of the Department of Psychiatry and Addictions, Saint Petersburg State University; ORCID: 0000-0003-4096-6208; e-mail: petrova_nn@mail.ru

�� : 03.08.2022 �� : 25.08.2022 ��: 30.08.2022

НЕЙРОПСИХИАТРИЧЕСКИЕ ПОСЛЕДСТВИЯ COVID-19 Текст научной статьи по специальности «Клиническая медицина»

Аннотация научной статьи по клинической медицине, автор научной работы — Петрова Н. Н.

Похожие темы научных работ по клинической медицине , автор научной работы — Петрова Н. Н.

NEUROPSYCHIATRIC CONSEQUENCES OF COVID-19

Текст научной работы на тему «НЕЙРОПСИХИАТРИЧЕСКИЕ ПОСЛЕДСТВИЯ COVID-19»